{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:56:59Z","timestamp":1785596219548,"version":"3.56.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"DOI":"10.1038\/s41380-026-03797-9","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:57:26Z","timestamp":1785589046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Alzheimer\u2019s disease research in China: insights, innovations, and future directions from the chinese preclinical Alzheimer\u2019s disease study (CPAS)"],"prefix":"10.1038","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1953-382X","authenticated-orcid":false,"given":"Binyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2667-281X","authenticated-orcid":false,"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"3797_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2024-102020","volume":"38","author":"N Zhi","year":"2025","unstructured":"Zhi N, Ren R, Qi J, Liu X, Yun Z, Lin S, et al. The China Alzheimer report 2025. Gen Psychiatr. 2025;38:e102020.","journal-title":"Gen Psychiatr"},{"key":"3797_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","volume":"14","author":"J Jia","year":"2018","unstructured":"Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, et al. The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14:483\u201391.","journal-title":"Alzheimers Dement"},{"key":"3797_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1474-4422(19)30290-X","volume":"19","author":"L Jia","year":"2020","unstructured":"Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020;19:81\u201392.","journal-title":"Lancet Neurol"},{"key":"3797_CR4","unstructured":"Healthy China Action Promotion Committee. Healthy China Action (2019\u20132030). https:\/\/www.gov.cn\/xinwen\/2019-07\/15\/content_5409694.htm (2019)."},{"key":"3797_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.14283\/jpad.2023.49","volume":"10","author":"L Cui","year":"2023","unstructured":"Cui L, Huang L, Pan FF, Wang Y, Huang Q, Guan YH, et al. Chinese Preclinical Alzheimer\u2019s disease Study (C-PAS): design and challenge from PET acceptance. J Prev Alzheimers Dis. 2023;10:571\u201380.","journal-title":"J Prev Alzheimers Dis"},{"key":"3797_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1567205017666200807193253","volume":"17","author":"L Huang","year":"2020","unstructured":"Huang L, Chen K, Liu Z, Guo Q. A conceptual framework for research on cognitive impairment with no dementia in memory clinic. Curr Alzheimer Res. 2020;17:517\u201325.","journal-title":"Curr Alzheimer Res"},{"key":"3797_CR7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2147\/NDT.S174293","volume":"14","author":"L Huang","year":"2018","unstructured":"Huang L, Chen KL, Lin BY, Tang L, Zhao QH, Lv YR, et al. Chinese version of montreal cognitive assessment basic for discrimination among different severities of Alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2018;14:2133\u201340.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3797_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"3797_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/JAD-140276","volume":"42","author":"MW Bondi","year":"2014","unstructured":"Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42:275\u201389.","journal-title":"J Alzheimers Dis"},{"key":"3797_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-150128","volume":"47","author":"EC Edmonds","year":"2015","unstructured":"Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. Subtle cognitive decline and biomarker staging in preclinical Alzheimer\u2019s disease. J Alzheimers Dis. 2015;47:231\u201342.","journal-title":"J Alzheimers Dis"},{"key":"3797_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol"},{"key":"3797_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01657-9","volume":"20","author":"FF Pan","year":"2020","unstructured":"Pan FF, Huang L, Chen KL, Zhao QH, Guo QH. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline. BMC Neurol. 2020;20:78.","journal-title":"BMC Neurol"},{"key":"3797_CR13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00259-025-07080-x","volume":"52","author":"X Mao","year":"2025","unstructured":"Mao X, Li A, Wang Y, Wang Y, Ren S, He K, et al. Association of objective subtle cognitive difficulties with amyloid-\u03b2 and tau deposition compared to subjective cognitive decline. Eur J Nucl Med Mol Imaging. 2025;52:1481\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3797_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/10731911231167537","volume":"31","author":"L Cui","year":"2024","unstructured":"Cui L, Zhang Z, Guo Y, Li Y, Xie F, Guo Q. Category switching test: a brief amyloid-\u03b2-sensitive assessment tool for mild cognitive impairment. Assessment. 2024;31:543\u201356.","journal-title":"Assessment"},{"key":"3797_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1046445","volume":"14","author":"Q Li","year":"2022","unstructured":"Li Q, Pan FF, Huang Q, Lo CZ, Xie F, Guo Q. Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta. Front Aging Neurosci. 2022;14:1046445.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR16","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1177\/10731911221144774","volume":"30","author":"L Huang","year":"2023","unstructured":"Huang L, Mei Z, Ye J, Guo Q. AMES: an automated self-administered scale to detect incipient cognitive decline in primary care settings. Assessment. 2023;30:2247\u201357.","journal-title":"Assessment"},{"key":"3797_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.046718","volume":"16","author":"MS Baek","year":"2020","unstructured":"Baek MS, Cho H, Kim H, Lee JH, Ryu YH, Lyoo CH. Longitudinal changes in A\/T\/N imaging biomarkers in early-onset and late-onset Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2020;16:e046718.","journal-title":"Alzheimer\u2019s Dement"},{"key":"3797_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13195-022-01061-0","volume":"14","author":"WJ Lee","year":"2022","unstructured":"Lee WJ, Cho H, Baek MS, Kim HK, Lee JH, Ryu YH, et al. Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease. Alzheimers Res Ther. 2022;14:121.","journal-title":"Alzheimers Res Ther"},{"key":"3797_CR19","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/alz.13728","volume":"20","author":"K Chen","year":"2024","unstructured":"Chen K, Wang M, Wu J, Zuo C, Huang Y, Wang W, et al. Incremental value of amyloid PET in a tertiary memory clinic setting in China. Alzheimer Dement. 2024;20:2516\u201325.","journal-title":"Alzheimer Dement"},{"key":"3797_CR20","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1007\/s00330-023-10366-z","volume":"34","author":"K He","year":"2024","unstructured":"He K, Li B, Huang L, Zhao J, Hua F, Wang T, et al. Positive rate and quantification of amyloid pathology with 18[F]florbetapir in the urban Chinese population. Eur radiology. 2024;34:3331\u201341.","journal-title":"Eur radiology"},{"key":"3797_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-221251","volume":"93","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Wang J, Wang Y, Liu X, He K, Guo Q, et al. 18F-AV45 PET and MRI reveal the influencing factors of Alzheimer\u2019s disease biomarkers in subjective cognitive decline population. J Alzheimers Dis. 2023;93:585\u201394.","journal-title":"J Alzheimers Dis"},{"key":"3797_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3233\/JAD-221166","volume":"94","author":"J Wang","year":"2023","unstructured":"Wang J, Wang M, Ren S, Huang L, He K, Li J, et al. The effect of gender and APOE \u025b4 status on brain amyloid-\u03b2 deposition in different age groups of mild cognitively impaired individuals: a PET-CT study. J Alzheimers Dis. 2023;94:763\u201375.","journal-title":"J Alzheimers Dis"},{"key":"3797_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202400008","volume":"7","author":"M Wang","year":"2024","unstructured":"Wang M, Zhang Z, Wang Y, Huang L, Huang Q, Ren S, et al. Effect of APOE \u025b4 status on brain amyloid-\u03b2 and cognitive function in amnestic and nonamnestic mild cognitive impairment: a [18F] florbetapir PET-CT study. Adv therapeutics. 2024;7:2400008.","journal-title":"Adv therapeutics"},{"key":"3797_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/VIW.20220080","volume":"4","author":"S Ren","year":"2023","unstructured":"Ren S, Pan Y, Li J, Huang L, Cui L, Jiang D, et al. The necessary of ternary amyloid classification for clinical practice: an alternative to the binary amyloid definition. VIEW. 2023;4:20220080.","journal-title":"VIEW"},{"key":"3797_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1089\/brain.2021.0054","volume":"12","author":"Q Huang","year":"2022","unstructured":"Huang Q, Ren S, Zhang T, Li J, Jiang D, Xiao J, et al. Aging-related modular architectural reorganization of the metabolic brain network. Brain Connect. 2022;12:432\u201342.","journal-title":"Brain Connect"},{"key":"3797_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2023.01.004","volume":"513","author":"S Ren","year":"2023","unstructured":"Ren S, Li J, Huang L, Huang Q, Chen K, Hu J, et al. Brain functional alterations and association with cognition in people with preclinical subjective cognitive decline and objective subtle cognitive difficulties. Neuroscience. 2023;513:137\u201344.","journal-title":"Neuroscience"},{"key":"3797_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-024-01385-z","volume":"16","author":"J Wang","year":"2024","unstructured":"Wang J, He Y, Chen X, Huang L, Li J, You Z, et al. Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer\u2019s disease: a [(18)F]PSS232 PET\/MRI study. Alzheimers Res Ther. 2024;16:9.","journal-title":"Alzheimers Res Ther"},{"key":"3797_CR28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1177\/0271678X241230733","volume":"44","author":"J Li","year":"2024","unstructured":"Li J, Huang Q, Qi N, He K, Li S, Huang L, et al. The associations between synaptic density and \u201cA\/T\/N\u201d biomarkers in Alzheimer\u2019s disease: an (18)F-SynVesT-1 PET\/MR study. J Cereb Blood Flow Metab. 2024;44:1199\u2013207.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3797_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12149-025-02025-8","volume":"39","author":"J Lu","year":"2025","unstructured":"Lu J, Chen K, Lin H, Ju Z, Ge J, Lu J, et al. Phenotype-specific metabolic patterns in Posterior cortical atrophy and early-onset typical Alzheimer\u2019s disease. Ann Nucl Med. 2025;39:506\u201317.","journal-title":"Ann Nucl Med"},{"key":"3797_CR30","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/s41380-024-02501-z","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Huang Q, Chen X, You Z, He K, Guo Q, et al. Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer\u2019s disease. Mol Psychiatry. 2024;29:2799\u2013809.","journal-title":"Mol Psychiatry"},{"key":"3797_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/0271678X231153730","volume":"43","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wang J, Xu X, You Z, Huang Q, Huang Y, et al. In vivo synaptic density loss correlates with impaired functional and related structural connectivity in Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2023;43:977\u201388.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3797_CR32","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1002\/alz.13775","volume":"20","author":"K He","year":"2024","unstructured":"He K, Li B, Wang J, Wang Y, You Z, Chen X, et al. APOE \u03b54 is associated with decreased synaptic density in cognitively impaired participants. Alzheimers Dement. 2024;20:3157\u201366.","journal-title":"Alzheimers Dement"},{"key":"3797_CR33","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/brain\/awaf425","volume":"149","author":"Y Luan","year":"2025","unstructured":"Luan Y, Huang Q, Wang J, Guan Y, Li B, Franzmeier N, et al. Synaptic density and tau pathology in Alzheimer\u2019s disease: a dual role in susceptibility and degeneration. Brain. 2025;149:1958\u201372.","journal-title":"Brain"},{"key":"3797_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61497-4","volume":"16","author":"Y Luan","year":"2025","unstructured":"Luan Y, Wang W, Huang Q, Wang Y, Nussbaumer J, Wang J, et al. Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer\u2019s disease. Nat Commun. 2025;16:6356.","journal-title":"Nat Commun"},{"key":"3797_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70333","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang J, Huang Q, Chen X, You Z, He K, Mao X, et al. Prediction of longitudinal synaptic loss in Alzheimer\u2019s disease using tau PET and plasma biomarkers. Alzheimers Dement. 2025;21:e70333.","journal-title":"Alzheimers Dement"},{"key":"3797_CR36","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1002\/alz.13817","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J, Huang Q, He K, Li J, Guo T, Yang Y, et al. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment. Alzheimers Dement. 2024;20:3876\u201388.","journal-title":"Alzheimers Dement"},{"key":"3797_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71473","volume":"22","author":"T Hu","year":"2026","unstructured":"Hu T, Wang Y, Wang J, Mao X, Ren S, He K, et al. Metabotropic glutamate receptor 5 is associated with plasma GFAP dependent on age. Alzheimers Dement. 2026;22:e71473.","journal-title":"Alzheimers Dement"},{"key":"3797_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70004","volume":"21","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang J, Chen X, Lin Z, You Z, He K, et al. Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer\u2019s disease in a sex-specific manner. Alzheimers Dement. 2025;21:e70004.","journal-title":"Alzheimers Dement"},{"key":"3797_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-0716-3774-6_13","volume":"2785","author":"R-V Elena","year":"2024","unstructured":"Elena R-V, Amit K, Mona-Lisa M, Konstantinos I, Filipa MR, Konstantinos C. Imaging neuroinflammation: quantification of astrocytosis in a multitracer PET approach. Methods Mol Biol. 2024;2785:195\u2013218.","journal-title":"Methods Mol Biol"},{"key":"3797_CR40","first-page":"4808","volume":"8","author":"JL Jin","year":"2015","unstructured":"Jin JL, Fang M, Zhao YX, Liu XY. Roles of sigma-1 receptors in Alzheimer\u2019s disease. Int J Clin Exp Med. 2015;8:4808\u201320.","journal-title":"Int J Clin Exp Med"},{"key":"3797_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.npep.2018.12.003","volume":"73","author":"KG Ma","year":"2019","unstructured":"Ma KG, Qian YH. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer\u2019s disease. Neuropeptides. 2019;73:96\u2013106.","journal-title":"Neuropeptides"},{"key":"3797_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.70030","volume":"16","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Ke Y, Ren C, Zhu J, Zhang Z, Cui L, et al. Temporal muscle thickness as a new biomarker: its association with alzheimer pathology and cognitive impairment in chinese adults. J Cachexia Sarcopenia Muscle. 2025;16:e70030.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3797_CR43","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3233\/JAD-220527","volume":"90","author":"S Ren","year":"2022","unstructured":"Ren S, Hu J, Huang L, Li J, Jiang D, Hua F, et al. Graph analysis of functional brain topology using minimum spanning tree in subjective cognitive decline. J Alzheimers Dis. 2022;90:1749\u201359.","journal-title":"J Alzheimers Dis"},{"key":"3797_CR44","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1002\/alz.14155","volume":"20","author":"L Huang","year":"2024","unstructured":"Huang L, Hu W, Cui L, Zhang Z, Lu Y, Li Q, et al. Temporo-frontoparietal hypoconnectivity as a biomarker for isolated language impairment in mild cognitive impairment: a cross-cohort comparison. Alzheimers Dement. 2024;20:6566\u201378.","journal-title":"Alzheimers Dement"},{"key":"3797_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fnagi.2018.00289","volume":"10","author":"L Zhu","year":"2018","unstructured":"Zhu L, Shu H, Liu D, Guo Q, Wang Z, Zhang Z. Apolipoprotein E \u03b54 specifically modulates the hippocampus functional connectivity network in patients with amnestic mild cognitive impairment. Front Aging Neurosci. 2018;10:289.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14380","volume":"21","author":"L Cui","year":"2025","unstructured":"Cui L, Zhang Z, Tu YY, Wang M, Guan YH, Li YH, et al. Association of precuneus A\u03b2 burden with default mode network function. Alzheimers Dement. 2025;21:e14380.","journal-title":"Alzheimers Dement"},{"key":"3797_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70239","volume":"21","author":"X Xu","year":"2025","unstructured":"Xu X, Yang X, Zhang J, Wang Y, Selim M, Zheng Y, et al. Choroid plexus free-water correlates with glymphatic function in Alzheimer\u2019s disease. Alzheimers Dement. 2025;21:e70239.","journal-title":"Alzheimers Dement"},{"key":"3797_CR48","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s00259-025-07716-y","volume":"53","author":"K He","year":"2026","unstructured":"He K, Wang J, Wu J, Chen X, Chen H, Li J, et al. Impaired glymphatic function is associated with synaptic loss in cognitive impairment. Eur J Nucl Med Mol Imaging. 2026;53:2799\u2013810.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3797_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00259-024-06862-z","volume":"52","author":"B Li","year":"2024","unstructured":"Li B, Chen H, Zheng Y, Xu X, You Z, Huang Q, et al. Loss of synaptic density in nucleus basalis of meynert indicates distinct neurodegeneration in Alzheimer\u2019s disease: the RJNB-D study. Eur J Nucl Med Mol imaging. 2024;52:134\u201344.","journal-title":"Eur J Nucl Med Mol imaging"},{"key":"3797_CR50","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1002\/alz.13845","volume":"20","author":"J Zhang","year":"2024","unstructured":"Zhang J, Chen H, Wang J, Huang Q, Xu X, Wang W, et al. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer\u2019s disease. Alzheimer Dement. 2024;20:3931\u201342.","journal-title":"Alzheimer Dement"},{"key":"3797_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.70238","volume":"46","author":"Q Li","year":"2025","unstructured":"Li Q, Cui L, Guan Y, Li Y, Xie F, Guo Q. Prediction model and nomogram for amyloid positivity using clinical and MRI features in individuals with subjective cognitive decline. Hum Brain Mapp. 2025;46:e70238.","journal-title":"Hum Brain Mapp"},{"key":"3797_CR52","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/S0140-6736(25)01389-3","volume":"406","author":"GB Frisoni","year":"2025","unstructured":"Frisoni GB, Aho E, Brayne C, Ciccarelli O, Dubois B, Fox NC, et al. Alzheimer\u2019s disease outlook: controversies and future directions. Lancet. 2025;406:1424\u201342.","journal-title":"Lancet"},{"key":"3797_CR53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1109\/JBHI.2024.3472011","volume":"29","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Sun K, Liu Y, Xie F, Guo Q, Shen D. A modality-flexible framework for Alzheimer\u2019s disease diagnosis following clinical routine. IEEE J Biomed Health Inf. 2025;29:535\u201346.","journal-title":"IEEE J Biomed Health Inf"},{"key":"3797_CR54","doi-asserted-by":"publisher","first-page":"11486","DOI":"10.1093\/cercor\/bhad381","volume":"33","author":"M Liu","year":"2023","unstructured":"Liu M, Cui L, Zhao Z, Ren S, Huang L, Guan Y, et al. Verifying and refining early statuses in Alzheimer\u2019s disease progression: a possibility from deep feature comparison. Cereb Cortex. 2023;33:11486\u201311500.","journal-title":"Cereb Cortex"},{"key":"3797_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s44172-024-00245-w","volume":"3","author":"K Sun","year":"2024","unstructured":"Sun K, Zhang Y, Liu J, Yu L, Zhou Y, Xie F, et al. Achieving multi-modal brain disease diagnosis performance using only single-modal images through generative AI. Commun Eng. 2024;3:96.","journal-title":"Commun Eng"},{"key":"3797_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102508","volume":"6","author":"G Lan","year":"2025","unstructured":"Lan G, Li B, Wang M, Barve A, Colin M, Bu\u00e9e L, et al. Plasma growth-associated protein 43 correlates with synaptic loss in Alzheimer\u2019s disease. Cell Rep Med. 2025;6:102508.","journal-title":"Cell Rep Med"},{"key":"3797_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1660755","volume":"17","author":"Y Wang","year":"2025","unstructured":"Wang Y, Cui L, Pan FF, Zhang Z, Huang L, Miao Y, et al. Validation of the robustness of blood-based biomarkers for predicting amyloid-\u03b2 positivity in Chinese populations. Front Aging Neurosci. 2025;17:1660755.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.832700","volume":"14","author":"FF Pan","year":"2022","unstructured":"Pan FF, Huang Q, Wang Y, Wang YF, Guan YH, Xie F, et al. Non-linear character of plasma amyloid beta over the course of cognitive decline in Alzheimer\u2019s continuum. Front Aging Neurosci. 2022;14:832700.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s43856-023-00295-9","volume":"3","author":"F Pan","year":"2023","unstructured":"Pan F, Huang Y, Cai X, Wang Y, Guan Y, Deng J, et al. Integrated algorithm combining plasma biomarkers and cognitive assessments accurately predicts brain beta-amyloid pathology. Commun Med. 2023;3:65.","journal-title":"Commun Med"},{"key":"3797_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1624513","volume":"17","author":"Y Lu","year":"2025","unstructured":"Lu Y, Cui L, Huang L, Xie F, Guo QH. Predicting amyloid status in mild cognitive impairment: the role of semantic intrusions combined with plasma biomarkers. Front Aging Neurosci. 2025;17:1624513.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR61","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233019","volume":"313","author":"J Wu","year":"2024","unstructured":"Wu J, Li B, Wang J, Huang Q, Chen X, You Z, et al. Plasma glial fibrillary acid protein and phosphorated Tau 181 association with presynaptic density-dependent tau pathology at (18)F-SynVesT-1 brain PET imaging. Radiology. 2024;313:e233019.","journal-title":"Radiology"},{"key":"3797_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70005","volume":"21","author":"FF Pan","year":"2025","unstructured":"Pan FF, Huang Q, Huang CC, Lu Y, Cui L, Huang L, et al. Associations of hippocampal volumes, brain hypometabolism, and plasma NfL with amyloid, tau, and cognitive decline. Alzheimers Dement. 2025;21:e70005.","journal-title":"Alzheimers Dement"},{"key":"3797_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13024-025-00906-0","volume":"20","author":"X Mao","year":"2025","unstructured":"Mao X, Wang Y, Luan Y, Wang Y, Wang J, Dai W, et al. Interplay between astrocyte reactivity and APOE \u03b54 status is associated with accelerated pTau-related tau pathology in Alzheimer\u2019s disease. Mol Neurodegener. 2025;20:115.","journal-title":"Mol Neurodegener"},{"key":"3797_CR64","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jad.2023.12.062","volume":"348","author":"L Huang","year":"2024","unstructured":"Huang L, Huang Q, Xie F, Guo Q. Neuropsychiatric symptoms in Alzheimer\u2019s continuum and their association with plasma biomarkers. J Affect Disord. 2024;348:200\u20136.","journal-title":"J Affect Disord"},{"key":"3797_CR65","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1038\/s41380-025-03149-z","volume":"30","author":"X Cheng","year":"2025","unstructured":"Cheng X, Wang Z, He K, Xia Y, Wang Y, Guo Q, et al. Plasma neurofilament light reflects more severe manifestation of Alzheimer\u2019s disease in men. Mol Psychiatry. 2025;30:5615\u201324.","journal-title":"Mol Psychiatry"},{"key":"3797_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70987","volume":"21","author":"FF Pan","year":"2025","unstructured":"Pan FF, Huang L, Wang Y, Huang Q, Guan YH, Li YH, et al. Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer\u2019s disease: role in disease stratification, pathological progression, and cognitive decline. Alzheimers Dement. 2025;21:e70987.","journal-title":"Alzheimers Dement"},{"key":"3797_CR67","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/cns.13962","volume":"28","author":"Y Huang","year":"2022","unstructured":"Huang Y, Li Y, Xie F, Guo Q. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients. CNS Neurosci Ther. 2022;28:2195\u2013205.","journal-title":"CNS Neurosci Ther"},{"key":"3797_CR68","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s43587-025-00904-3","volume":"5","author":"G Lan","year":"2025","unstructured":"Lan G, Wang M, Gonzalez-Ortiz F, Zhang L, Li A, Li B, et al. Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer\u2019s disease in a multicenter and multiethnic aging population. Nat Aging. 2025;5:1601\u201318.","journal-title":"Nat Aging"},{"key":"3797_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-023-00371-z","volume":"12","author":"F Pan","year":"2023","unstructured":"Pan F, Lu Y, Huang Q, Xie F, Yang J, Guo Q. The potential impact of clinical factors on blood-based biomarkers for Alzheimer\u2019s disease. Transl Neurodegener. 2023;12:39.","journal-title":"Transl Neurodegener"},{"key":"3797_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.820385","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Pan F, Xie F, He R, Guo Q. Correlation between urine formaldehyde and cognitive abilities in the clinical spectrum of Alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:820385.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1046066","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang Y, Zhu J, Guan Y, Xie F, Cai X, et al. Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:1046066.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR72","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/13872877241309117","volume":"103","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhu L, He K, Cui L, Pan F, Guan Y, et al. Urinary formic acid is associated with cerebral amyloid deposition and glucose metabolism in memory clinic patients. J Alzheimers Dis. 2025;103:1102\u201311.","journal-title":"J Alzheimers Dis"},{"key":"3797_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47897-y","volume":"15","author":"T Chen","year":"2024","unstructured":"Chen T, Pan F, Huang Q, Xie G, Chao X, Wu L, et al. Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer\u2019s disease. Nat Commun. 2024;15:3796.","journal-title":"Nat Commun"},{"key":"3797_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71307","volume":"22","author":"W Fu","year":"2026","unstructured":"Fu W, Chao X, Wang Y, Liu S, Wang J, Huang Q, et al. Bile acids are associated with baseline and longitudinal amyloid and tau pathology in patients with Alzheimer\u2019s disease. Alzheimers Dement. 2026;22:e71307.","journal-title":"Alzheimers Dement"},{"key":"3797_CR75","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1007\/s00415-023-11626-0","volume":"270","author":"H Chu","year":"2023","unstructured":"Chu H, Huang C, Miao Y, Ren C, Guan Y, Xie F, et al. The association of subjective sleep characteristics and plasma biomarkers of Alzheimer\u2019s disease pathology in older cognitively unimpaired adults with higher amyloid-\u03b2 burden. J Neurol. 2023;270:3008\u201321.","journal-title":"J Neurol"},{"key":"3797_CR76","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12877-021-02383-8","volume":"21","author":"H Su","year":"2021","unstructured":"Su H, Sun X, Li F, Guo Q. Association between handgrip strength and cognition in a Chinese population with Alzheimer\u2019s disease and mild cognitive impairment. BMC Geriatr. 2021;21:459.","journal-title":"BMC Geriatr"},{"key":"3797_CR77","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.clnu.2024.05.024","volume":"43","author":"H Chu","year":"2024","unstructured":"Chu H, Huang C, Guan Y, Xie F, Chen M, Guo Q. The associations between nutritional status and physical frailty and Alzheimer\u2019s disease plasma biomarkers in older cognitively unimpaired adults with positive of amyloid-\u03b2 PET. Clin Nutr. 2024;43:1647\u201356.","journal-title":"Clin Nutr"},{"key":"3797_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14921","volume":"30","author":"Y Guo","year":"2024","unstructured":"Guo Y, Huang L, Kuang J, Sun T, Zhang X, Tian H, et al. Physical function is associated with cognitive status, brain amyloid-beta deposition, and blood biomarkers in Chinese Han population. CNS Neurosci Ther. 2024;30:e14921.","journal-title":"CNS Neurosci Ther"},{"key":"3797_CR79","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s40120-024-00666-x","volume":"13","author":"H Chu","year":"2024","unstructured":"Chu H, Huang C, Xie F, Guo Q. The association between constipation and positron emission tomography and blood-based biomarkers in older cognitively unimpaired adults with higher amyloid-\u03b2 burden. Neurol Ther. 2024;13:1701\u201315.","journal-title":"Neurol Ther"},{"key":"3797_CR80","doi-asserted-by":"publisher","first-page":"649","DOI":"10.14283\/jpad.2024.62","volume":"11","author":"L Cui","year":"2024","unstructured":"Cui L, Tu YY, Zhang Z, Guo YH, Guan YH, Xie F, et al. Associations and potential multiple mechanisms between subjective hearing loss and cognitive impairment. J Prev Alzheimers Dis. 2024;11:649\u201360.","journal-title":"J Prev Alzheimers Dis"},{"key":"3797_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23512-7","volume":"25","author":"C Ren","year":"2025","unstructured":"Ren C, Hu T, Zhu J, Chu H, Guo Q. Sarcopenia index is associated with Alzheimer\u2019s disease, mild cognitive impairment and their mortality in Chinese adults aged 65 and older. BMC Public Health. 2025;25:2277.","journal-title":"BMC Public Health"},{"key":"3797_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1651723","volume":"17","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Tu Y, Ren C, Ke Y, Guo Q. Elevated gonadotropins and risk of dementia in Chinese adults aged over 80: a cross-sectional study. Front Aging Neurosci. 2025;17:1651723.","journal-title":"Front Aging Neurosci"},{"key":"3797_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70932","volume":"21","author":"YY Tu","year":"2025","unstructured":"Tu YY, Cui L, Zhang Z, Wang M, Guan YH, Li YH, et al. Subjective sleep characteristics in non-demented adults: domain-specific associations with multimodal Alzheimer\u2019s disease biomarkers. Alzheimers Dement. 2025;21:e70932.","journal-title":"Alzheimers Dement"},{"key":"3797_CR84","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/nu15051243","volume":"15","author":"X Jiang","year":"2023","unstructured":"Jiang X, Guo Y, Cui L, Huang L, Guo Q, Huang G. Study of diet habits and cognitive function in the chinese middle-aged and elderly population: the association between folic acid, B Vitamins, Vitamin D, Coenzyme Q10 supplementation and cognitive ability. Nutrients. 2023;15:1243.","journal-title":"Nutrients"},{"key":"3797_CR85","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3390\/nu15102309","volume":"15","author":"X Jiang","year":"2023","unstructured":"Jiang X, Cui L, Huang L, Guo Y, Huang G, Guo Q. The relationship between beverages consumption and cognitive impairment in middle-aged and elderly chinese population. Nutrients. 2023;15:2309.","journal-title":"Nutrients"},{"key":"3797_CR86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"Dyck","year":"2023","unstructured":"Dyck, CHv, Swanson CJ, Aisen P, Bateman RJ, Chen C, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"3797_CR87","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Evans CD, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in early Alzheimer\u2019s disease. N Engl J Med. 2021;384:1691\u2013704.","journal-title":"N Engl J Med"},{"key":"3797_CR88","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.14283\/jpad.2024.153","volume":"11","author":"F Jessen","year":"2024","unstructured":"Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, et al. Progress in the treatment of Alzheimer\u2019s disease is needed \u2013 position statement of European Alzheimer\u2019s Disease Consortium (EADC) investigators. J Prev Alzheimer\u2019s Dis. 2024;11:1212\u20138.","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"3797_CR89","doi-asserted-by":"publisher","first-page":"11794","DOI":"10.7150\/thno.44152","volume":"10","author":"Y Shen","year":"2020","unstructured":"Shen Y, Hua L, Yeh CK, Shen L, Ying M, Zhang Z, et al. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer\u2019s disease. Theranostics. 2020;10:11794\u2013819.","journal-title":"Theranostics"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03797-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03797-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:02:33Z","timestamp":1785592953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03797-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":89,"alternative-id":["3797"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03797-9","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All the authors have reviewed and approved this manuscript. All the authors declare no conflicts of interest that may directly or indirectly influence the manuscript\u2019s content.","order":2,"name":"Ethics","label":"Consent statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}